000			03887nam a2200469 i 4500
999			_c362937 _d362937 _x1
001			362937
003			ES-MaUEC
005			20230102121635.0
006			a||||fo|||| 00| 0
007			cr nn 008mamaa
008			210628s2021 sz a s |||| 0|eng d
020			_a9783030744625
024	7		_a10.1007/978-3-030-74462-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM340 _b2021 EB
245	0	0	_aDirect Oral Anticoagulants : _bfrom Pharmacology to Clinical Practice _cedited by Riccardo Proietti, Ahmed AlTurki, Nicola Ferri, Vincenzo Russo, T. Jared Bunch
250			_aFirst edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
264		4	_c2021
300			_a1 recurso en línea (VI, 283 páginas) _b36 ilustraciones, 34 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aArchivo de texto _bPDF
505	0		_aThe Coagulative cascade -- Clinical Indications for Direct Acting Oral Anticoagulants -- Pharmacokinetic and pharmaco-dynamic of DOACDrug-drug interaction with DO-ACsDirect Oral Anticoagulant Reversal for Management of Bleeding and Emergent Surgery -- Risk stratification for and use of DOAC therapies for stroke prevention in patient with atrial fibrillationUse of DOAC in patients with kidney disease -- Anticoagulation In Elderly Patients With Atrial FibrallationThe "Obesity Paradox" And The Use Of NOAC -- Direct Oral Anticoagulation In Cancer Patients -- DOACs and Dementia in Patients with Atrial Fibrillation -- Non-Vitamin K Antagonists and Cardiac Implantable Electronic Devices -- Direct Oral Anticoagulants and Atrial Fibrillation Ablation -- DOAC therapy in patients post left atrial appendage occlusion or isolation -- Use of Direct Oral Anticoagulants after Transcatheter Aortic Valve Replacement -- Use of Direct Oral Anticoagulants after Percutaneous Coronary Intervention -- Direct oral anticoagulants and Left Ventricular Thrombosis: the evidence for a good therapeutic approach.
520			_aThis book concisely covers the latest developments in the application of direct oral anticoagulants (DOACs) within cardiovascular medicine. It details the pharmacodynamics and pharmacokinetic mechanisms of DOACs and their application in treating patients with conditions ranging from coronary heart disease through kidney disease and cancer, including their perioperative management. Direct Oral Anticoagulants: From Pharmacology to Clinical Practice systematically describes the underlying mechanisms associated with DOACs and their use to treat a range of conditions and is an indispensable resource for all trainee and practicing physicians in a range of disciplines seeking a concise up-to-date resource on the topic.
988			_aSpringer_Medicine_2021
650		7	_2embne _9144124 _aAnticoagulantes
700	1		_aProietti, Riccardo _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aAlTurki, Ahmed _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aFerri, Nicola _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aRusso, Vincenzo _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aBunch, T. Jared _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030744618
776	0	8	_iPrinted edition: _z9783030744632
776	0	8	_iPrinted edition: _z9783030744649
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-74462-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b02/2022 _dz _ek _zSI